Rates of recurrent preterm birth by maternal body habitus in women receiving 17α-hydroxyprogesterone caproate*

By Timofeev Julia   Feghali Maisa   Boyle Annelee   Istwan Niki   Rhea Debbie   Driggers Rita W.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 26, Iss. 9, 2013-06 ,pp. : 881-884

Informa Healthcare

Access to resources Recommend Favorite

Recurrent preterm birth in women treated with 17 α-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy

By Coleman Suzanne   Wallace Lisa   Alexander Jeffrey   Istwan Niki  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Iss. 7, 2012-07 ,pp. : 1034-1038

Informa Healthcare

Access to resources Recommend Favorite

Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery

By González-Quintero Víctor Hugo   Istwan Niki   Rhea Debbie   Smarkusky Loren   Hoffman M. Camille   Stanziano Gary  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 20, Iss. 3, 2007-01 ,pp. : 249-252

Informa Healthcare

Access to resources Recommend Favorite

Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate

By Szychowski Jeff M.   Berghella Vincenzo   Owen John   Hankins Gary   Iams Jay D.   Sheffield Jeanne S.   Perez-Delboy Annette   Wing Deborah A.   Guzman Edwin R.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Iss. 12, 2012-12 ,pp. : 2686-2689

Informa Healthcare

Access to resources Recommend Favorite

Embryo-fetal toxicity signals for 17α-hydroxyprogesterone caproate in high-risk pregnancies: A review of the non-clinical literature for embryo-fetal toxicity with progestins

By Christian M. S.   Brent R. L.   Calda P.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 20, Iss. 2, 2007-01 ,pp. : 89-112

Informa Healthcare

Access to resources Recommend Favorite